NAIROBI (Xinhua) --
Experts drawn from the pharmaceutical industry in
Africa on Monday called for strategic partnerships between both
the public and private sectors to improve healthcare delivery in
the sub-Saharan region.
Speaking in Nairobi
during a conference on Improving Access to Medicines through
Partnerships in Sub-Saharan Africa organized by Takeda, a
pharmaceutical company, the team of experts noted that a
majority of patients arrive too late for healthcare due to lack
of awareness on health issues or lack of access to healthcare
Co-Founder and Executive Chairman of Goodlife Pharmacies, said
billions of dollars have been pumped into the sub-Saharan region
to combat ailments such as HIV/AIDS, malaria and tuberculosis
often yielding tremendous results.
“However, the tide
has changed. Other diseases, especially Non-Communicable
Diseases (NCDs) such as heart disease, diabetes and cancer are
now the leading cause of death,” said Ruxin in a keynote
He said there was a
need to rationalize healthcare systems and channel funds toward
increased access to basic health services and access to
According to data
from International Finance Corporation, sub-Saharan Africa is
ranked as having the worst health on average in the world. The
region has 11 percent of the world’s population but carries 24
percent of the global disease burden.
Ruxin noted that in
Kenya alone, non-communicable diseases account for more than 50
percent of total hospital admissions and over 55 percent of
Disease such as
cancer, hypertension, and diabetes are becoming commonplace due
to more sedentary lifestyles and shifts in eating habits.
increasingly become an economic burden to the family unit in
Africa and a leading cause for emerging consumers to fall back
It is now estimated
that Kenyans spend about 100 million dollars annually overseas
on cancer treatment.
Ruxin noted that it
was critical for the renewed effort to improve healthcare in the
region to focus on developing sustainable, mutually beneficial
partnerships that span from the public to the private sector.
Tanzania works to control
DAR ES SALAAM Tanzania (Xinhua) --
Tanzanian health authorities said on
Monday plans were afoot to control rising antibiotics resistance
among patients in the east African nation.
Mohamed Kambi, the
country’s chief medical officer, said the government was laying
groundwork for a national action plan to control the rising
trend of antibiotics resistance.
He said One-Health,
a collaborative approach involving experts in veterinary
medicine and those in the health sector, would help tackle
antibiotic resistance in a holistic manner.
came after two key studies carried out in Tanzania exposed
antibiotic resistance that threatened treatment effectiveness,
with experts urging a review of prescription practices.
Kambi said the
national action plan to curb antibiotic resistance would, apart
from experts on animal medicine, involve the National Food and
Drugs Authority (TFDA), the pharmaceutical authorities and all
health stakeholders in the country.
“The action plan
will also address the behavioral, legal and social implications
of bacterial resistance,” said Kambi.
Researchers said the
common antibiotics being prescribed routinely in Tanzania were
now losing effectiveness due to lack of clear policies guiding
medical practitioners on how and when to give medications.
resistant organisms are passed from animals on to humans through
consumption of meat, milk and other animal products.
Last year, Said
Aboud, an expert on bacteriology, analyzed how antibiotics
resistance was affecting the country in many sectors, through
his publication in the Centre for Disease Dynamics Economics and
One key issue he
tackled was the contribution of animal products in the rise of
Aboud said: “This
contributes to the decline towards ineffective antibiotics, like
an approaching siren, getting louder and louder.”
Last year, the heads
of state and government at the United Nations General Assembly
in New York committed to taking a broad, coordinated approach to
address the root causes of antibiotic resistance across multiple
sectors, especially human health, animal health and agriculture.
The World Health
Organization (WHO) says globally, 480, 000 people develop
multi-drug resistant tuberculosis each year, and drug resistance
is starting to complicate the fight against HIV and malaria.